May value-based healthcare practices contribute to comprehensive care for cancer patients? A systematic literature review

Silva, Ana Carolina Pereira de Vasconcelos; Araujo, Bianca Menezes; Spiegel, Thais; Reis, Augusto da Cunha

doi:10.1016/j.jcpo.2022.100350

Cited by 7 publications

(7 citation statements)

References 157 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…WHO has developed a common set of principles of IC that are comprehensive, equitable, sustainable, holistic, preventive, empowering, respectful, collaborative, co-produced, endowed with rights and responsibilities, governed through shared accountability, evidence-informed, led by whole-systems thinking and Ethical ( World Health Organization, 2015 ). Furthermore, value-based healthcare has become an international consensus ( Daniels et al, 2022 ; de Vasconcelos et al, 2022 ; Kokko, 2022 ). While WHO provides a thorough and widely-accepted IC framework, but there’s potential for further refinement, context-specific adaptation, and inclusion of new concepts as healthcare evolves.…”

Section: Discussionmentioning

confidence: 99%

Mapping the scientific research on integrated care: a bibliometric and social network analysis

Guo,

Zhou,

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

BackgroundIntegrated care (IC) is the cornerstone of the sustainable development of the medical and health system. A thorough examination of the existing scientific literature on IC is essential for assessing the present state of knowledge on this subject. This review seeks to offer an overview of evidence-based knowledge, pinpoint existing knowledge gaps related to IC, and identify areas requiring further research.MethodsData were retrieved from the Web of Science Core Collection, from 2010 to 2020. Bibliometrics and social network analysis were used to explore and map the knowledge structure, research hotspots, development status, academic groups and future development trends of IC.ResultsA total of 7,501 articles were obtained. The number of publications on IC was rising in general. Healthcare science services were the most common topics. The United States contributed the highest number of articles. The level of collaboration between countries and between authors was found to be relatively low. The keywords were stratified into four clusters: IC, depression, integrative medicine, and primary health care. In recent years, complementary medicine has become a hotspot and will continue to be a focus.ConclusionThe study provides a comprehensive analysis of global research hotspots and trends in IC, and highlights the characteristics, challenges, and potential solutions of IC. To address resource fragmentation, collaboration difficulties, insufficient financial incentives, and poor information sharing, international collaboration needs to be strengthened to promote value co-creation and model innovation in IC. The contribution of this study lies in enhancing people’s understanding of the current state of IC research, guiding scholars to discover new research perspectives, and providing valuable references for researchers and policymakers in designing and implementing effective IC strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

Mapping the scientific research on integrated care: a bibliometric and social network analysis

Guo,

Zhou,

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

show abstract

“…, 2020), which is broadly employed for conducting systematic literature reviews, mainly in the health field (D'Andreamatteo et al. , 2015; Hallam and Contreras, 2018; Silva et al. , 2022).…”

Section: Methodsmentioning

confidence: 99%

“…In this phase, the authors followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) protocol (Moher et al, 2009;Nascimento et al, 2021;Santos et al, 2020;Silva et al, 2021;Tanaro et al, 2020), which is broadly employed for conducting systematic literature reviews, mainly in the health field (D'Andreamatteo et al, 2015;Hallam and Contreras, 2018;Silva et al, 2022). PRISMA helps to reduce the risks of elaborating incorrect reports and assures a more precise and comprehensive description of systematic Lean healthcare: bibliometric indicators reviews and meta-analysis (Kelendar et al, 2020;Liberati et al, 2009).…”

Section: Data Collection and Article Classificationmentioning

confidence: 99%

Measuring the current state-of-the-art in lean healthcare literature from the lenses of bibliometric indicators

Santos

Reis

Souza

et al. 2022

BIJ

View full text Add to dashboard Cite

PurposeLean healthcare (LHC) applies lean philosophy in the healthcare sector to promote a culture of continuous improvement through the elimination of non-value-added activities. Studies on the subject can be classified as conceptual (theoretical) or analytical (applied). Therefore, this research compares bibliometric indicators between conceptual and analytical articles on LHC.Design/methodology/approachFor data collection, the PRISMA Protocol was employed, and 488 articles published from 2009 to 2021, indexed in the Scopus and WoS databases, were retrieved.FindingsThis study reveals how conceptual and analytical LHC studies are organized in terms of the most relevant journals, articles, institutions, countries, the total number of citations, collaboration networks (co-authorship, international collaboration network and institutional collaboration network) and main co-words.Originality/valueOnly four papers conducting bibliometric analysis on LHC studies were identified in the Scopus and Web of Science databases. In addition, none of these papers compared conceptual and analytical bibliometric indicators to reveal the evolution, organization and trends of each category. Therefore, this work is not only the first to make this comparison but also the first to analyze the collaboration between authors, institutions and countries in relation to studies on LHC. The analyses performed in this work allow one new possible understanding, by researchers and health professionals, of the literature behavior in this field of study.

show abstract

“…Value encompasses clinical effectiveness; safety, costs, and economic implications; ethical, social, cultural and legal issues; and organizational and environmental aspects, as well as wider implications for the patient, relatives, caregivers, and the population [ 14 , 19 ]. In practice, value in HTA is frequently (mis)interpreted as the cost-effectiveness of a technology [ 20 ]. It is important to recognize the broad dimensions of value beyond clinical and economic values and that some important dimensions cannot be readily enumerated quantitatively [ 21 ].…”

Section: What Does Hta Mean When Applied To Cancer Medicines?mentioning

confidence: 99%

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

et al. 2022

View full text Add to dashboard Cite

Background: Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resource allocation through a systematic value assessment of health technology. This paper reviews the challenges in conducting HTA for cancer medicines arising from oncology trial designs and uncertainties of safety-efficacy data. Methods: Multiple databases (PubMed, Scopus and Google Scholar) and grey literature (public health agencies and governmental reports) were searched to inform this policy narrative review. Results: A lack of robust efficacy-safety data from clinical trials and other relevant sources of evidence has made HTA for cancer medicines challenging. The approval of cancer medicines through expedited pathways has increased in recent years, in which surrogate endpoints or biomarkers for patient selection have been widely used. Using these surrogate endpoints has created uncertainties in translating surrogate measures into patient-centric clinically (survival and quality of life) and economically (cost-effectiveness and budget impact) meaningful outcomes, with potential effects on diverting scarce health resources to low-value or detrimental interventions. Potential solutions include policy harmonization between regulatory and HTA authorities, commitment to generating robust post-marketing efficacy-safety data, managing uncertainties through risk-sharing agreements, and using value frameworks. Conclusion: A lack of robust efficacy-safety data is a central problem for conducting HTA of cancer medicines, potentially resulting in misinformed resource allocation.

show abstract

May value-based healthcare practices contribute to comprehensive care for cancer patients? A systematic literature review

Cited by 7 publications

References 157 publications

Mapping the scientific research on integrated care: a bibliometric and social network analysis

Mapping the scientific research on integrated care: a bibliometric and social network analysis

Measuring the current state-of-the-art in lean healthcare literature from the lenses of bibliometric indicators

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

Contact Info

Product

Resources

About